Cardiology

Evolocumab improves endothelial function in cardiovascular patients, suggesting potential long-term benefits for heart health.

Stress echocardiography predicts five-year cardiovascular risk, guiding treatment for high-risk patients and offering reassurance for low-risk cases.

Alternative LDL cholesterol-lowering strategy offers similar outcomes to statins, with fewer side effects and better safety.

Systemic inflammation mediates psoriasis severity’s link to cardiovascular disease, highlighting its importance in clinical care.

Troponin monitoring reveals hidden cardiac risks in cancer immunotherapy, aiding early detection of myocarditis.

LA stiffness index correlates strongly with LVFPs in acute heart failure, showing superior diagnostic accuracy over standard measures, with potential to improve non-invasive management strategies.

Recaticimab cuts LDL-C by over 60% with 12-week dosing, offering a promising lipid-lowering option for nonfamilial hypercholesterolemia patients on stable statin therapy.

Kidney function decline in ATTR-CM predicts worse outcomes. Monitoring eGFR changes can guide interventions, improving clinical care for this progressive disease.